Hamilton Thorne (CVE:HTL) Shares Up 4.3% – Should You Buy?

Hamilton Thorne Ltd. (CVE:HTL)’s share price traded up 4.3% during mid-day trading on Tuesday . The company traded as high as C$1.45 and last traded at C$1.45. 25,700 shares were traded during trading, a decline of 27% from the average session volume of 35,118 shares. The stock had previously closed at C$1.39.

Hamilton Thorne Stock Up 4.3%

The firm’s 50 day simple moving average is C$1.45 and its 200 day simple moving average is C$1.45. The company has a market cap of C$149.69 million, a price-to-earnings ratio of 58.94 and a beta of 0.54. The company has a quick ratio of 2.25, a current ratio of 3.20 and a debt-to-equity ratio of 16.60.

About Hamilton Thorne

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.